Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Life Sciences|December 21, 2013
Endothelin-1 overexpression and endothelial nitric oxide synthase knock-out induce different pathological responses in the heart of male and female miceNicolas Vignon-Zellweger, Katharina Relle, Jan Rahnenführer, et al.British Journal of Pharmacology|June 14, 2006
NO-independent activation of soluble guanylate cyclase prevents disease progression in rats with 5/6 nephrectomyPhilipp Kalk, Michael Godes, Katharina Relle, et al.Clinical Laboratory|September 6, 2011
Renoprotective effects of combined endothelin-converting enzyme/neutral endopeptidase inhibitor SLV338 in acute and chronic experimental renal damageYuliya Sharkovska, Philipp Kalk, Karoline von Websky, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 1, 2009
Does endothelin B receptor deficiency ameliorate the induction of peritoneal fibrosis in experimental peritoneal dialysis?Philipp Kalk, Matthias Rückert, Michael Godes, et al.Journal of the American Society of Nephrology : JASN|February 23, 2007
Soluble CD154 is a unique predictor of nonfatal and fatal atherothrombotic events in patients who have end-stage renal disease and are on hemodialysisBerthold Hocher, Lutz Liefeldt, Thomas Quaschning, et al.Canadian Journal of Physiology and Pharmacology|June 3, 2008
Additional lack of iNOS attenuates diastolic dysfunction in aged ET-1 transgenic micePhilipp Kalk, Dirk Westermann, Sophia Herzfeld, et al.Canadian Journal of Physiology and Pharmacology|September 2, 2008
Pulmonary fibrosis in L-NAME-treated mice is dependent on an activated endothelin systemPhilipp Kalk, Alexander Mach, Christa Thone-Reineke, et al.Journal of Hypertension|July 9, 2010
Nitric oxide-independent stimulation of soluble guanylate cyclase reduces organ damage in experimental low-renin and high-renin modelsYuliya Sharkovska, Philipp Kalk, Bettina Lawrenz, et al.Hypertension (Dallas, Tex. : 1979)|February 23, 2011
Endothelin-converting enzyme/neutral endopeptidase inhibitor SLV338 prevents hypertensive cardiac remodeling in a blood pressure-independent mannerPhilipp Kalk, Yuliya Sharkovska, Elena Kashina, et al.The Journal of Physiology|March 31, 2007
Cell-type specific interaction of endothelin and the nitric oxide system: pattern of prepro-ET-1 expression in kidneys of L-NAME treated prepro-ET-1 promoter-lacZ-transgenic miceTorsten Slowinski, Philipp Kalk, Maren Christian, et al.Pageof 2